• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国儿童肠胃炎发病率降低与国家医疗索赔数据库中早期轮状病毒疫苗接种率的相关性。

Reduction in gastroenteritis in United States children and correlation with early rotavirus vaccine uptake from national medical claims databases.

机构信息

National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.

出版信息

Pediatr Infect Dis J. 2010 Jun;29(6):489-94. doi: 10.1097/INF.0b013e3181d95b53.

DOI:10.1097/INF.0b013e3181d95b53
PMID:20354464
Abstract

BACKGROUND

We sought to estimate rotavirus disease reduction among children in hospital and office settings in the 4 US regions following rotavirus vaccine introduction and to estimate vaccine uptake.

METHODS

Two national third-party payer medical claims databases were used to examine the number of visits for gastroenteritis per annual nongastroenteritis visits among children aged <5 years during July 2003 to June 2008 in hospital and office settings. The gastroenteritis burden attributable to rotavirus was computed as the excess of all gastroenteritis visits during rotavirus seasons above the baseline of visits during nonrotavirus periods. Rotavirus vaccine uptake was estimated by comparing claims for rotavirus vaccine with those for diphtheria-tetanus-acellular pertussis vaccines.

RESULTS

In the South, Northeast, and Midwest, the typical winter-spring gastroenteritis peak due to rotavirus was markedly dampened in 2007-2008. Compared with the mean for 3 prevaccine seasons, the excess gastroenteritis visits that occurred during the 2007-2008 rotavirus season was reduced by >90% among infants in all care settings in 3 regions and by >70% among children aged 1 to 4 years. In the West, disease reductions were lower (53%-63% reduction among hospitalized infants). At the onset of the 2007-2008 season, coverage with > or =1 rotavirus vaccine dose was an estimated 57% among infants, 17% among children aged 1 year, and 0 among those aged 2 to 4 years.

CONCLUSIONS

The rotavirus burden in 2007-2008 was markedly reduced in all US regions and exceeded that explained by only direct protection of the youngest vaccinated children.

摘要

背景

我们旨在评估美国四个地区在轮状病毒疫苗接种后医院和门诊环境中儿童轮状病毒疾病的减少情况,并估计疫苗接种率。

方法

我们使用了两个全国性第三方支付者医疗索赔数据库,以评估 2003 年 7 月至 2008 年 6 月期间 5 岁以下儿童每年非胃肠炎就诊次数中,胃肠炎就诊次数与非胃肠炎就诊次数的比值。通过比较轮状病毒季节期间所有胃肠炎就诊次数与非轮状病毒时期就诊次数的基线,计算出轮状病毒引起的胃肠炎负担。轮状病毒疫苗接种率通过比较轮状病毒疫苗和白喉、破伤风、无细胞百日咳疫苗的索赔来估计。

结果

在南部、东北部和中西部,典型的冬季-春季轮状病毒胃肠炎高峰在 2007-2008 年明显减弱。与前 3 个疫苗接种季节的平均值相比,在所有护理环境中,所有年龄组婴儿在 2007-2008 年轮状病毒季节期间发生的胃肠炎就诊次数比前 3 个季节的平均值减少了超过 90%,1 至 4 岁儿童减少了超过 70%。在西部,疾病减少幅度较低(住院婴儿减少 53%-63%)。在 2007-2008 年季节开始时,估计有超过 1 剂轮状病毒疫苗的覆盖率在婴儿中为 57%,1 岁儿童中为 17%,2 至 4 岁儿童中为 0。

结论

在所有美国地区,2007-2008 年的轮状病毒负担明显减少,超过了仅对最年轻接种儿童的直接保护所解释的负担。

相似文献

1
Reduction in gastroenteritis in United States children and correlation with early rotavirus vaccine uptake from national medical claims databases.美国儿童肠胃炎发病率降低与国家医疗索赔数据库中早期轮状病毒疫苗接种率的相关性。
Pediatr Infect Dis J. 2010 Jun;29(6):489-94. doi: 10.1097/INF.0b013e3181d95b53.
2
Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States.五价轮状病毒疫苗在美国预防肠胃炎的效果。
Pediatrics. 2010 Feb;125(2):e208-13. doi: 10.1542/peds.2009-1246. Epub 2010 Jan 25.
3
Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States.美国针对儿童严重轮状病毒肠胃炎开展的基于人群的主动监测。
Pediatrics. 2008 Dec;122(6):1235-43. doi: 10.1542/peds.2007-3378.
4
Effectiveness of an incomplete RotaTeq (RV5) vaccination regimen in preventing rotavirus gastroenteritis in the United States.在美国,不完全的 Rotateq(RV5)疫苗接种方案预防轮状病毒胃肠炎的效果。
Pediatr Infect Dis J. 2013 Mar;32(3):278-83. doi: 10.1097/INF.0b013e318275328f.
5
Estimated burden of rotavirus-associated diarrhea in ambulatory settings in the United States.美国门诊环境中轮状病毒相关性腹泻的估计负担。
Pediatrics. 2010 Feb;125(2):e191-8. doi: 10.1542/peds.2008-1262. Epub 2010 Jan 25.
6
Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule.轮状病毒疫苗纳入澳大利亚国家儿童免疫接种计划后,轮状病毒相关急性胃肠炎发病率降低。
Pediatr Infect Dis J. 2011 Jan;30(1 Suppl):S25-9. doi: 10.1097/INF.0b013e3181fefdee.
7
The effect of rotavirus immunization on rotavirus gastroenteritis hospitalization rates in military dependents.轮状病毒免疫接种对军人眷属轮状病毒胃肠炎住院率的影响。
Vaccine. 2011 Jan 17;29(4):650-9. doi: 10.1016/j.vaccine.2010.11.041. Epub 2010 Dec 1.
8
All-cause gastroenteritis and rotavirus-coded hospitalizations among US children, 2000-2009.2000-2009 年美国儿童因各种原因导致的肠胃炎和轮状病毒编码的住院情况。
Clin Infect Dis. 2012 Aug;55(4):e28-34. doi: 10.1093/cid/cis443. Epub 2012 Apr 27.
9
Reduction in gastroenteritis with the use of pentavalent rotavirus vaccine in a primary practice.五价轮状病毒疫苗在初级医疗实践中的应用可降低肠胃炎发生率。
Pediatrics. 2010 Jul;126(1):e40-5. doi: 10.1542/peds.2009-2069. Epub 2010 Jun 29.
10
Reduction in acute gastroenteritis hospitalizations among US children after introduction of rotavirus vaccine: analysis of hospital discharge data from 18 US states.轮状病毒疫苗问世后美国儿童急性肠胃炎住院人数减少:来自 18 个美国州的医院出院数据分析。
J Infect Dis. 2010 Jun 1;201(11):1617-24. doi: 10.1086/652403.

引用本文的文献

1
Quantitative Benefit-Risk Models Used for Rotavirus Vaccination: A Systematic Review.用于轮状病毒疫苗接种的定量效益-风险模型:一项系统评价。
Open Forum Infect Dis. 2020 Mar 12;7(4):ofaa087. doi: 10.1093/ofid/ofaa087. eCollection 2020 Apr.
2
Surveillance data confirm multiyear predictions of rotavirus dynamics in New York City.监测数据证实了纽约市多年来对轮状病毒动态的预测。
Sci Adv. 2020 Feb 26;6(9):eaax0586. doi: 10.1126/sciadv.aax0586. eCollection 2020 Feb.
3
Validation of Acute Gastroenteritis-related International Classification of Diseases, Clinical Modification Codes in Pediatric and Adult US Populations.
验证急性胃肠炎相关的国际疾病分类,临床修正码在儿科和成人美国人群。
Clin Infect Dis. 2020 May 23;70(11):2423-2427. doi: 10.1093/cid/ciz846.
4
Trends in the Laboratory Detection of Rotavirus Before and After Implementation of Routine Rotavirus Vaccination - United States, 2000-2018.轮状病毒常规疫苗接种前后实验室检测趋势 - 美国,2000-2018 年。
MMWR Morb Mortal Wkly Rep. 2019 Jun 21;68(24):539-543. doi: 10.15585/mmwr.mm6824a2.
5
Molecular characterisation of rotavirus strains detected during a clinical trial of the human neonatal rotavirus vaccine (RV3-BB) in Indonesia.在印度尼西亚进行的人类新生轮状病毒疫苗(RV3-BB)临床试验中检测到的轮状病毒株的分子特征。
Vaccine. 2018 Sep 18;36(39):5872-5878. doi: 10.1016/j.vaccine.2018.08.027. Epub 2018 Aug 23.
6
Longer-term Direct and Indirect Effects of Infant Rotavirus Vaccination Across All Ages in the United States in 2000-2013: Analysis of a Large Hospital Discharge Data Set.2000-2013 年美国所有年龄段婴幼儿轮状病毒疫苗接种的长期直接和间接效果:大型医院出院数据的分析。
Clin Infect Dis. 2019 Mar 5;68(6):976-983. doi: 10.1093/cid/ciy580.
7
A decade of experience with rotavirus vaccination in the United States - vaccine uptake, effectiveness, and impact.美国轮状病毒疫苗接种十年经验:疫苗接种率、有效性和影响。
Expert Rev Vaccines. 2018 Jul;17(7):593-606. doi: 10.1080/14760584.2018.1489724. Epub 2018 Jul 2.
8
Rotavirus vaccines: why continued investment in research is necessary.轮状病毒疫苗:为何持续投入研究是必要的。
Curr Clin Microbiol Rep. 2018 Mar;5(1):73-81. Epub 2018 Jan 18.
9
Physician perspectives on vaccination and diagnostic testing in children with gastroenteritis: A primary care physician survey.初级保健医生对肠胃炎患儿疫苗接种和诊断检测的看法:一项初级保健医生调查。
Paediatr Child Health. 2017 Sep;22(6):317-321. doi: 10.1093/pch/pxx078. Epub 2017 Jun 17.
10
Rotavirus shedding following administration of RV3-BB human neonatal rotavirus vaccine.接种RV3-BB人新生儿轮状病毒疫苗后的轮状病毒排毒情况。
Hum Vaccin Immunother. 2017 Aug 3;13(8):1908-1915. doi: 10.1080/21645515.2017.1323591. Epub 2017 May 8.